Author Bio
Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.
What happened
The roller-coaster-like trajectory that has been Co-Diagnostics (NASDAQ:CODX) stock price climbed another hill on Thursday. The healthcare-testing specialist s shares closed over 21% higher on the day, due largely to news of a fresh patent awarded to the company.
Co-Diagnostics, Inc Strengthens Intellectual Property Portfolio with New International CoPrimer™ Patent
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Co-Diagnostics Inc strengthens its intellectual property portfolio with patent award in the Republic of Korea for its CoPrimer technology
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Co-Diagnostics, Inc Receives CE Marking for Direct Saliva SARS-CoV-2 Test
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Co-Diagnostics, Inc says its Logix Smart SARS-CoV-2 DS (Direct Saliva) test has obtained regulatory authorization to be sold as an in vitro diagnostic for the diagnosis of coronavirus (COVID-19) in markets that accept CE markings
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.